A Prospective, Open-Label, Exploratory Clinical Study of Adebrelimab Combined with Apatinib in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Immune Checkpoint Inhibitors

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 7a1bca7d5810312ac6177677851c74da22441ac5
First added on: Oct 10, 2026